Vatanidipine

CAS No. 116308-55-5

Vatanidipine( —— )

Catalog No. M34043 CAS No. 116308-55-5

Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 299 Get Quote
5MG 454 Get Quote
10MG 621 Get Quote
25MG 911 Get Quote
50MG 1224 Get Quote
100MG 1575 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vatanidipine
  • Note
    Research use only, not for human use.
  • Brief Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
  • Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116308-55-5
  • Formula Weight
    686.8
  • Molecular Formula
    C41H42N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCCC1=CC=C(C=C1)N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)(=O)C=5C(C(C(OC)=O)=C(C)NC5C)C6=CC(N(=O)=O)=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GV-58

    GV-58 is a potent, selective N-Type and P/Q-type Ca2+ Channel agonist with EC50 of 7.2 and 8.8 uM.

  • Ziconotide Acetate

    Ziconotide is an analgesic agent and has been used to treat neuropathic and non-neuropathic pain. Ziconotide acts by binding to N-type calcium channels situated on the terminal part of primary afferent neurons of the nociceptive pathway therefore reducing synaptic transmission with potent antinociceptive effects.

  • Cis-22a

    Cis-22a is a TRPV6 inhibitor (IC50 = 0.32 μM), which exhibits selectivity against related TRPV channels and calcium channels. cis-22a displays antiproliferative effects on T47D human breast cancer cells.